China Single-Use Bioreactors Market (2026-2031)
The China Single-Use Bioreactors Market was valued at $314.3 Million in 2026 and projected to reach to $623.3 Million by 2031, representing a compound annual growth rate of 14.7%. China's single-use bioreactors market is positioned for sustained growth through 2031, driven by expanding biopharmaceutical manufacturing infrastructure and government policies promoting domestic production capabilities.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
China Single-Use Bioreactors Market Trends and Insights
- China is rapidly adopting single-use bioreactor technology driven by increased biopharmaceutical manufacturing capacity and government support for domestic vaccine and therapeutic production.
- The 14.7% compound annual growth rate reflects China's strategic shift toward modernizing biotech infrastructure and reducing dependency on imported manufacturing systems. China's market growth is underpinned by rising investments in cell and gene therapy platforms, expanding contract manufacturing organizations (CMOs), and regulatory incentives for advanced manufacturing.
- China's biopharmaceutical sector is scaling production capabilities to meet both domestic demand and export opportunities, positioning single-use bioreactors as critical infrastructure.
- Between 2026 and 2031, China is expected to capture significant market share within Asia Pacific, driven by cost competitiveness, manufacturing scale, and accelerating R&D spending in regenerative medicine and monoclonal antibody production..
Key Market Statistics
- CAGR (2026-2031) 14.7% CAGR
- Market Size, 2026 ~USD 314.3 Million
- Forecast, 2031 ~USD 623.3 Million
- Country China
China Single-Use Bioreactors Market Overview
Rapid Market Expansion :
China's single-use bioreactors market is projected to grow from USD 314.3 million in 2026 to USD 623.3 million by 2031, representing a 14.7% CAGR, outpacing the global growth rate of 12%.
Government-Backed Growth :
Chinese government initiatives supporting domestic vaccine and therapeutic production are accelerating adoption of single-use bioreactor technology across the biopharmaceutical sector.
Manufacturing Capacity Surge :
Increased biopharmaceutical manufacturing capacity in China is driving demand for flexible, scalable single-use bioreactor solutions that reduce contamination risks and operational costs.
Domestic Production Focus :
China's strategic shift toward self-sufficiency in biologics production is creating substantial opportunities for single-use bioreactor adoption among local manufacturers and contract manufacturers.
China Single-Use Bioreactors Market Dynamics
- The 14.7% CAGR reflects strong demand from both established pharmaceutical companies and emerging biotech firms investing in advanced manufacturing technologies. The market will benefit from increasing adoption of single-use systems due to their flexibility, reduced capital expenditure, and lower contamination risks compared to traditional stainless steel bioreactors.
- As China continues to develop its vaccine production ecosystem and therapeutic manufacturing base, single-use bioreactors will become increasingly critical to meeting domestic and export demand..
Market Ecosystem
SINGLE-USE BIOREACTORS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Deployed six 4,000 L ABEC CSR single-use bioreactors at its Pune facility to support large-scale manufacturing of Novavax’s NVX-CoV2373 vaccine. | Established 24,000 L of single-use production capacity | The 4,000 L systems doubled productivity per unit of floor space, supported accelerated facility startup, and reduced manufacturing cost per dose. |
 |
Implemented Cytiva Xcellerex Disposable Reactors (XDR) for mAb and bispecific antibody production. | Demonstrated that XDR bioreactors can be used effectively for antibody production | The system met all benchmarks for viable cell density, viability, integral viable cell count (IVC), and titer | The real-time CO2 monitoring proved effective, allowing maintenance of optimal culture conditions. |
 |
Implemented Sartorius Ambr and BIOSTAT STR platforms, ranging from process-development systems to 500 L and 2,000 L single-use bioreactors, at its San Diego biologics facility. | Enabled consistent scale-up from development to GMP production, improved process-data continuity, and supported seamless technology transfer for Phase I through commercial biologics manufacturing. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- China's single-use bioreactors market will nearly double from USD 314.3M (2026) to USD 623.3M (2031), growing at 14.7% CAGR.
- China's biopharmaceutical manufacturing expansion and government biotech initiatives are primary drivers of single-use bioreactor adoption.
- China's cost-competitive manufacturing ecosystem and CMO growth position the country as a regional hub for bioreactor deployment.
- China's investments in cell therapy, gene therapy, and vaccine production will sustain double-digit market growth through 2031.
Single-Use Bioreactors Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | CELL & GENE THERAPY (Molecule Type) |
| Forecast Period | 2026-2031 |
| Growth Rate | CAGR of 12% from 2026 to 2031 |
| Largest Segment | BIOPRODUCTION (Application) |
| Market Size Base Year (Billions) | ~USD 5.44 (2026) |
| Revenue Forecast (Billions) | ~USD 9.58 (2031) |
| Segments Covered | Product, Scale Range, Type, Molecule Type, Cell Type, Application, Process Mode, End User |
China Single-Use Bioreactors Market Report Segmentation
8 segment dimensions are covered across the global market.
By Product
- Other Products
- Single-Use Assemblies
- Single-Use Bags
- Single-Use Bioreactor Systems
By Scale Range
- 101-500 L Bioreactors
- 11-100 L Bioreactors
- 501-1,500 L Bioreactors
- >1,500 L Bioreactors
- <=10 L Bioreactors
By Type
- 101-500 L Bioreactors
- 11-100 L Bioreactors
- 2D Single-Use Bags
- 3D Single-Use Bags
- 501-1,500 L Bioreactors
- >1,500 L Bioreactors
- Bubble-Column Single-Use Bioreactors
- Fixed-Bed Single-Use Bioreactors
- Other Single-Use Bioreactors
- Stirred-Tank Single-Use Bioreactors
- Wave-Induced Single-Use Bioreactors
- <=10 L Bioreactors
By Molecule Type
- Cell & Gene Therapy
- Monoclonal Antibodies
- Therapeutic Proteins & Peptides
- Vaccines
By Cell Type
- Bacterial Cells
- Mammalian Cells
- Other Cells
- Yeast Cells
By Application
- Bioproduction
- Process Development
- Research & Development
By Process Mode
- Batch Process Mode
- Feb-Batch Process Mode
- Fed-Batch Process Mode
- Perfusion/Continuous Process Mode
By End User
- Academic & Research Institutes
- Cros & Cmos
- Pharmaceutical & Biotechnology Companies
Target Audience
- Biopharmaceutical Manufacturers : Chinese and multinational biotech companies need market insights to plan capacity expansion, select bioreactor suppliers, and align production strategies with government initiatives.
- Contract Manufacturing Organizations (CMOs) : CMOs operating in China require detailed market data to forecast client demand, justify capital investments in single-use technology, and remain competitive in the growing domestic market.
- Equipment Suppliers & Vendors : Bioreactor manufacturers and equipment suppliers need China-specific market intelligence to identify growth opportunities, understand customer requirements, and develop localized product strategies.
- Investment & Private Equity Firms : Investors evaluating opportunities in China's biotech sector need comprehensive market analysis to assess growth potential, identify acquisition targets, and evaluate market entry strategies.
- Government & Policy Advisors : Chinese government agencies and policy makers require market data to evaluate the effectiveness of biopharmaceutical support initiatives and guide future regulatory and investment decisions.
Reasons to Buy this Report
- Market-Specific Growth Data : Access precise forecasts and historical data exclusive to China's market, enabling accurate business planning and investment decisions tailored to this high-growth region.
- Competitive Intelligence : Understand China-specific market dynamics, local competitor strategies, and manufacturing trends to identify opportunities and threats in this rapidly expanding market.
- Government Policy Insights : Gain detailed analysis of Chinese government initiatives supporting biopharmaceutical manufacturing and how they directly impact single-use bioreactor adoption and market growth.
- Investment & Expansion Strategy : Leverage China-focused market segmentation and demand forecasts to guide manufacturing facility investments, partnerships, and go-to-market strategies in this key region.
- Supply Chain Optimization : Identify local manufacturing capacity trends and production bottlenecks specific to China to optimize supply chain decisions and distribution strategies.
Frequently asked questions
What is the current market size of single-use bioreactors in China?
China's single-use bioreactors market was valued at USD 314.3 million in 2026 and is projected to grow to USD 623.3 million by 2031.
What is the growth rate of China's single-use bioreactors market?
China's single-use bioreactors market is growing at a compound annual growth rate (CAGR) of 14.7% from 2026 to 2031.
What factors are driving growth in China's single-use bioreactors market?
China's market growth is driven by expanding biopharmaceutical manufacturing capacity, government support for domestic biotech, rising CMO investments, and increased R&D in cell and gene therapies.
How does China's single-use bioreactors market compare to global trends?
China's 14.7% CAGR significantly outpaces the global market CAGR of 12%, reflecting China's accelerated biotech infrastructure modernization and manufacturing scale-up.
Which applications are driving single-use bioreactor demand in China?
China's demand is primarily driven by monoclonal antibody production, vaccine manufacturing, cell therapy platforms, and gene therapy development across domestic and export markets.
RESEARCH METHODOLOGY
This research study relied extensively on secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global single-use bioreactors market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives at major market players, and industry consultants, to gather and validate critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with primary research inputs to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single-use bioreactors market. The secondary sources used for this study include National Institutes of Health (NIH), National Institute for Bioprocessing Research and Training (NIBRT), Society for Biological Engineering (SBE), Bio-Process Systems Alliance (BPSA), Biotechnology Innovation Organization (BIO), BioProcess International, BioPharm International, BioPlan Associates, Organisation for Economic Co-operation and Development (OECD) R&D Expenditure, National Center for Biotechnology Information (NCBI), World Health Organization (WHO), Food and Drug Administration (FDA); corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; and trade, business, and professional associations, among others. These sources were also used to obtain key information on major players, market classification and segmentation aligned with industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and to assess the market's future prospects. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-use bioreactors market. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed where applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Single-use bioreactors (SUBs) or disposable bioreactors consist of a disposable bag instead of a typical stainless steel or glass culture vessel. SUBs are based on single-use technology, which uses disposable components to manufacture biopharmaceutical products. The key benefits of single-use bioreactors include reduced risk of cross-contamination, lower capital and operational costs, faster turnaround times, and greater manufacturing flexibility. These advantages make single-use systems particularly attractive for producing biologics, vaccines, and personalized medicines, where flexibility, speed, and sterility are paramount.
The report presents the market size for single-use bioreactor systems, single-use bags, single-use assemblies, and other products that can be incorporated with single-use bioreactors.
Key Stakeholders
- Manufacturers of single-use bioreactors and associated products
- Distributors of single-use bioreactors and related products
- Pharmaceutical and biotechnology companies
- Contract manufacturing companies (CMOs)
- Contract research organizations (CROs)
- Academic and research institutes
- Life sciences companies
- Market research and consulting firms
- Venture capitalists and investors
- Government organizations
- Medical institutes and universities
- Private research firms
Report Objectives
- To define, describe, and forecast the global single-use bioreactors market based on product, type, cell type, process mode, molecule type, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall single-use bioreactors market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, and R&D activities in the single-use bioreactors market
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the single-use bioreactors market
Available customizations:
Based on the given market data, MarketsandMarkets offers customization to meet the company’s specific needs. The following customization options are available for this report:
Portfolio Assessment- Product Matrix, which gives a detailed comparison of the product portfolios of the top four companies.
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Geographical Analysis
- A further breakdown of the Rest of Europe single-use bioreactors market, by country
- A further breakdown of the Rest of Asia Pacific single-use bioreactors market, by country
- A further breakdown of the Rest of Latin America single-use bioreactors market, by country
Get the Full Single-Use Bioreactors Market Report
Full forecast, segment splits, and company analysis for all Single-Use Bioreactors Market.
- Canada Single-Use Bioreactors Market
- US Single-Use Bioreactors Market
- Germany Single-Use Bioreactors Market
- UK Single-Use Bioreactors Market
- France Single-Use Bioreactors Market
- Italy Single-Use Bioreactors Market
- Spain Single-Use Bioreactors Market
- South Korea Single-Use Bioreactors Market
- Japan Single-Use Bioreactors Market
- India Single-Use Bioreactors Market
- Australia Single-Use Bioreactors Market
- Brazil Single-Use Bioreactors Market
- Mexico Single-Use Bioreactors Market
- Rest Of Europe Single-Use Bioreactors Market
- Rest Of Asia Pacific Single-Use Bioreactors Market
- Rest Of Latin America Single-Use Bioreactors Market
- Rest Of GCC Countries Single-Use Bioreactors Market
- Saudi Arabia (Ksa) Single-Use Bioreactors Market
- United Arab Emirates (UAE) Single-Use Bioreactors Market
- GCC Countries Single-Use Bioreactors Market
- Rest Of Middle East Single-Use Bioreactors Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
